MMDA eyes EDSA busway for faster transport of COVID-19 vaccines

enablePagination: false
maxItemsPerPage: 10
totalITemsFound:
maxPaginationLinks: 10
maxPossiblePages:
startIndex:
endIndex:

Metro Manila (CNN Philippines, February 27) — The Metropolitan Manila Development Authority may use EDSA's inner bus lanes for the speedy transport of the first batch of COVID-19 vaccines on Sunday, its chief said.

In a virtual briefing on Saturday, MMDA Chairman Benhur Abalos said the agency is looking to use the EDSA bus lanes, which are exclusive for accredited public utility buses, for the smooth delivery of Sinovac vaccines after arrival at the airport.

"May options tayo, puwede natin gamitin ang bus carousel at kung hindi naman, ‘yung katabi mismo ng bus carousel," he said.

[Translation: We have options, we can use the bus carousel, or if not, the lanes beside the bus carousel.]

The MMDA chief said the vials would be transported from the Villamor Air Base in Pasay City to a facility in Marikina City, and will be delivered to Veteran's Memorial Medical Center in Quezon City.

Abalos refused to disclose details of the route when asked, but he stressed the government is ready to receive and distribute the vaccines for the planned inoculations.

"'Yung distribution nito (vaccines), lahat ng gagawin ay naka-plantsa na po," he said.

[Translation: The distribution of these (vaccines), everything that needs to be done has been ironed out.]

Government officials on Friday said the 600,000 doses donated by the Chinese government would arrive in the Philippines on February 28.

RELATED: IATF approves use of Sinovac's COVID-19 vaccine for health workers

The inter-agency task force on the government's COVID-19 response gave its go signal to use Sinovac's COVID-19 vaccine for medical workers despite questions on its efficacy.

READ: FDA only 'flagged' 50% efficacy of Sinovac, but still safe for health workers, Vergeire says

Department of Health Spokesperson Maria Rosario Vergeire in the same briefing reiterated that while clinical trials showed lower efficacy among healthcare workers in Brazil, the National Immunization Technical Advisory Group and the DOH's Technical Advisory Group still advised that the vaccines could be given to medical frontliners.